{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:50:01Z","timestamp":1770364201654,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.eimce.2026.503053","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:38:35Z","timestamp":1770309515000},"page":"503053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational study"],"prefix":"10.1016","volume":"44","author":[{"given":"Rosa Anna","family":"Passerotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Taccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Puma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Tamburrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Torti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503053_bib0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimce.2026.503053_bib0145","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00277-020-04144-w","article-title":"An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality","volume":"99","author":"Kara Ali","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.eimce.2026.503053_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224465","volume":"14","author":"Trecarichi","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2026.503053_bib0155","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.ijantimicag.2023.106806","volume":"61","author":"Trecarichi","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503053_bib0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/IDR.S163293","article-title":"Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations","volume":"11","author":"Tohamy","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.eimce.2026.503053_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients: review of the literature from a clinical perspective","volume":"42","author":"Biehl","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.eimce.2026.503053_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1382500","article-title":"Increased rate of multidrug-resistant gram-negative bacterial infections in hospitalized immunocompromised pediatric patients","volume":"14","author":"Khafaja","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.eimce.2026.503053_bib0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/antibiotics11111459","article-title":"Risk factors and outcomes for multidrug-resistant Pseudomonas aeruginosa infection in immunocompromised patients","volume":"11","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.eimce.2026.503053_bib0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J Infect"},{"issue":"suppl 2","key":"10.1016\/j.eimce.2026.503053_bib0185","article-title":"339. OPAT outcomes in patients with immunocompromise","volume":"10","author":"Mahoney","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eimce.2026.503053_bib0190","first-page":"619","article-title":"Outpatient parenteral antibiotic therapy in patients with haematological malignancies: a pilot study of an early discharge strategy","volume":"9","author":"Johansson","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.eimce.2026.503053_bib0195","first-page":"1643","article-title":"Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors","volume":"30","author":"Robins","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.eimce.2026.503053_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107263","article-title":"Safety and efficacy of outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis of randomized clinical trials","volume":"64","author":"Mohammed","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2026.503053_bib0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy745","article-title":"2018 IDSA clinical practice guideline for the management of outpatient parenteral antimicrobial therapy (OPAT)","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2026.503053_bib0210","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0891-5520(05)70030-1","article-title":"Practical considerations of outpatient infusion therapy in the HIV arena","volume":"12","author":"Lutz","year":"1998","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.eimce.2026.503053_bib0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/jpm12040650","article-title":"Implementing a personalized antimicrobial stewardship program for women with gynecological cancers and healthcare-associated infections","volume":"12","author":"Di Giambenedetto","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.eimce.2026.503053_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s44155-022-00026-w","article-title":"Health-related quality of life and factors relevant to return to work in cancer survivors after hospital discharge: a descriptive cross-sectional study","volume":"2","author":"Mizuno","year":"2022","journal-title":"Discov Soc Sci Health"},{"key":"10.1016\/j.eimce.2026.503053_bib0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12955-024-02227-0","article-title":"Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database","volume":"22","author":"Dixit","year":"2024","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.eimce.2026.503053_bib0230","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.athoracsur.2020.06.066","article-title":"Risk factors for nonhome discharge after esophagectomy for neoplastic disease","volume":"111","author":"Heid","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.eimce.2026.503053_bib0235","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/jac\/dkv478","article-title":"Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people","volume":"71","author":"Mujal","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503053_bib0240","doi-asserted-by":"crossref","first-page":"ofaa398","DOI":"10.1093\/ofid\/ofaa398","article-title":"Safety of outpatient parenteral antimicrobial therapy in nonagenarians","volume":"7","author":"Shrestha","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eimce.2026.503053_bib0245","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2026.503053_bib0250","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid, Spain 2025. ISBN 978-94-92671-29-5. EAU Guidelines Office, Arnhem, the Netherlands. Available from: https:\/\/uroweb.org\/guidelines\/urological-infections\/chapter\/introduction."},{"key":"10.1016\/j.eimce.2026.503053_bib0255","article-title":"U.S. Food and Drug Administration. FDA updates warnings for oral and injectable fluoroquinolone antibiotics","volume":"Vol. 17","year":"2016"},{"key":"10.1016\/j.eimce.2026.503053_bib0260","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-025-02619-4","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in Germany","author":"Tometten","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.eimce.2026.503053_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0327535","article-title":"Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: observational single-center study","volume":"20","author":"Toschi","year":"2025","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2026.503053_bib0270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eimc.2024.04.001","article-title":"Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: characteristics, safety, and efficacy analysis","volume":"42","author":"Giuliano","year":"2024","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:39:08Z","timestamp":1770309548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X26000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2529993X26000079"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503053","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational study","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"503053"}}